Header Logo

Connection

CHRIS AMOS to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Biomarkers, Tumor.
CHRIS AMOS
Connection Strength
4.508
Biomarkers, Tumor
  1. Gene expression in tumor and adjacent normal tissues in lung adenocarcinoma subtypes. BMC Cancer. 2025 Jul 14; 25(1):1169.
    View in: PubMed
    Score: 0.516
  2. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival. Mol Carcinog. 2020 06; 59(6):640-650.
    View in: PubMed
    Score: 0.358
  3. Gene set selection via LASSO penalized regression (SLPR). Nucleic Acids Res. 2017 Jul 07; 45(12):e114.
    View in: PubMed
    Score: 0.296
  4. Next generation sequencing and its applications in HPV-associated cancers. Oncotarget. 2017 Jan 31; 8(5):8877-8889.
    View in: PubMed
    Score: 0.287
  5. Unsupervised gene set testing based on random matrix theory. BMC Bioinformatics. 2016 Nov 04; 17(1):442.
    View in: PubMed
    Score: 0.282
  6. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
    View in: PubMed
    Score: 0.215
  7. Genomic sequencing in cancer. Cancer Lett. 2013 Nov 01; 340(2):161-70.
    View in: PubMed
    Score: 0.215
  8. Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden. Sci Rep. 2024 06 03; 14(1):12732.
    View in: PubMed
    Score: 0.119
  9. Re: On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst. 2003 Jan 01; 95(1):74-5; author reply 77-8.
    View in: PubMed
    Score: 0.108
  10. Genetic Variation and Recurrent Haplotypes on Chromosome 6q23-25 Risk Locus in Familial Lung Cancer. Cancer Res. 2021 06 15; 81(12):3162-3173.
    View in: PubMed
    Score: 0.096
  11. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 2021 03 15; 81(6):1607-1615.
    View in: PubMed
    Score: 0.095
  12. Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma. Ann Thorac Surg. 2021 11; 112(5):1575-1583.
    View in: PubMed
    Score: 0.094
  13. A new efficient method to detect genetic interactions for lung cancer GWAS. BMC Med Genomics. 2020 10 30; 13(1):162.
    View in: PubMed
    Score: 0.093
  14. Cancer Biomarkers and Big Data: A Planetary Science Approach. Cancer Cell. 2020 12 14; 38(6):757-760.
    View in: PubMed
    Score: 0.092
  15. Functional annotation of melanoma risk loci identifies novel susceptibility genes. Carcinogenesis. 2020 06 17; 41(4):452-457.
    View in: PubMed
    Score: 0.091
  16. Transcriptome-wide association study reveals candidate causal genes for lung cancer. Int J Cancer. 2020 04 01; 146(7):1862-1878.
    View in: PubMed
    Score: 0.087
  17. Sex-specific gene and pathway modeling of inherited glioma risk. Neuro Oncol. 2019 01 01; 21(1):71-82.
    View in: PubMed
    Score: 0.082
  18. A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis. Mol Cancer Res. 2019 01; 17(1):109-119.
    View in: PubMed
    Score: 0.080
  19. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer. 2018 06 01; 142(11):2303-2312.
    View in: PubMed
    Score: 0.077
  20. Somatic mutation analysis in melanoma using targeted next generation sequencing. Exp Mol Pathol. 2017 10; 103(2):172-177.
    View in: PubMed
    Score: 0.075
  21. Melanoma Expression Genes Identified through Genome-Wide Association Study of?Breslow Tumor Thickness. J Invest Dermatol. 2017 01; 137(1):253-257.
    View in: PubMed
    Score: 0.069
  22. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer. J Thorac Oncol. 2016 Jan; 11(1):52-61.
    View in: PubMed
    Score: 0.067
  23. A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):193-200.
    View in: PubMed
    Score: 0.066
  24. Reply to Z. Li et al. J Clin Oncol. 2015 Nov 01; 33(31):3674-5.
    View in: PubMed
    Score: 0.065
  25. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing. Exp Mol Pathol. 2015 Oct; 99(2):240-4.
    View in: PubMed
    Score: 0.065
  26. C-reactive protein as a marker of melanoma progression. J Clin Oncol. 2015 Apr 20; 33(12):1389-96.
    View in: PubMed
    Score: 0.063
  27. Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer. Genet Epidemiol. 2015 Mar; 39(3):197-206.
    View in: PubMed
    Score: 0.062
  28. Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol Carcinog. 2014 Sep; 53(9):711-21.
    View in: PubMed
    Score: 0.055
  29. Role of selected genetic variants in lung cancer risk in African Americans. J Thorac Oncol. 2013 Apr; 8(4):391-7.
    View in: PubMed
    Score: 0.055
  30. Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients. Carcinogenesis. 2013 Feb; 34(2):299-306.
    View in: PubMed
    Score: 0.054
  31. Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2012 May; 133(1):347-55.
    View in: PubMed
    Score: 0.051
  32. A single-nucleotide polymorphism in tumor suppressor gene SEL1L as a predictive and prognostic marker for pancreatic ductal adenocarcinoma in Caucasians. Mol Carcinog. 2012 May; 51(5):433-8.
    View in: PubMed
    Score: 0.049
  33. A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res (Phila). 2011 Apr; 4(4):514-21.
    View in: PubMed
    Score: 0.048
  34. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2009 Dec 16; 101(24):1731-2; author reply 1732.
    View in: PubMed
    Score: 0.044
  35. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006 Aug 10; 24(23):3789-98.
    View in: PubMed
    Score: 0.034
  36. Prognostic stratification in DLBCL patients with aberrant MYC gene. Br J Haematol. 2024 Nov; 205(5):1782-1793.
    View in: PubMed
    Score: 0.030
  37. Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers. Nat Commun. 2024 Apr 29; 15(1):3621.
    View in: PubMed
    Score: 0.030
  38. Expression of a 65 kDa oncofetal protein in human prostatic carcinoma. Oncol Rep. 2003 Sep-Oct; 10(5):1387-92.
    View in: PubMed
    Score: 0.028
  39. Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiol Biomarkers Prev. 2022 10 04; 31(10):1966-1974.
    View in: PubMed
    Score: 0.027
  40. A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma. Br J Cancer. 2022 11; 127(9):1691-1700.
    View in: PubMed
    Score: 0.026
  41. Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 2021 03; 17(3):e1009254.
    View in: PubMed
    Score: 0.024
  42. A gene expression-based immune signature for lung adenocarcinoma prognosis. Cancer Immunol Immunother. 2020 Sep; 69(9):1881-1890.
    View in: PubMed
    Score: 0.022
  43. Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. J Invest Dermatol. 2019 11; 139(11):2352-2358.e3.
    View in: PubMed
    Score: 0.021
  44. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2019 05; 28(5):935-942.
    View in: PubMed
    Score: 0.021
  45. A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2018 01; 27(1):86-95.
    View in: PubMed
    Score: 0.019
  46. Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. Clin Cancer Res. 2017 Dec 15; 23(24):7550-7557.
    View in: PubMed
    Score: 0.019
  47. A genetic variant near the PMAIP1/Noxa gene is associated with increased bleomycin sensitivity. Hum Mol Genet. 2011 Feb 15; 20(4):820-6.
    View in: PubMed
    Score: 0.012
  48. GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example. PLoS One. 2009 Aug 04; 4(8):e6511.
    View in: PubMed
    Score: 0.011
  49. Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome. J Histochem Cytochem. 2003 Dec; 51(12):1665-72.
    View in: PubMed
    Score: 0.007
  50. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer. 2003 Oct 20; 107(1):84-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.